The AstraZeneca vaccine is safe in the opinion of the EMA: they can resume vaccinations.
After suspension as a precaution by AIFA and EMA, administrations of the AstraZeneca vaccine resume. The EMA, the European Medicines Agency, gave the ok the superiority of the benefits over the risks and, therefore, the safety of the vaccine.
The investigations and analyzes of these days they have not ascertained the presence of a correlation between vaccine administrations and thrombosis cases reported in various European countries.
The experts who carried out the analyzes on the 30 suspected cases out of over 5 million doses administered, taking into account methods and times of administration and general conditions of individuals who have had adverse effects, they did not consider that there were any anomalies nor greater risk factors than the general average.
A new warning in the vaccine
In any case, the EMA has specified that one should be added new vaccine warning as there are still some unclear aspects on very rare cases of cerebral thrombosis for which still other analyzes will have to be done.
However, he communicates that the risks are really remote compared to the very serious damage that Covid-19 can cause.
The vaccine plan in Italy
According to Italy's very ambitious vaccination plan, about80% of the population will be vaccinated by the end of the summer and to achieve this, half a million vaccines need to be administered every day from mid-April.
Currently, the average is 170 vaccinations per day, but they should be used in the second quarter 10 million vaccines AstraZeneca and, in the third quarter, others 24,8 million of doses.
